 |
|
If you need to get a quote for any product, or have any questions, please fill in the
following contact form, we will contact you within 24 hours. If your have an account with us, click here to login to retrieve your information.
| Your Contact Information (Required *) |
| First Name* |
|
| Last Name* |
|
| E-Mail* |
|
| Company Name* |
|
| Address |
|
| City |
|
| State |
|
| Zip |
|
| Country |
|
| Phone |
|
| Fax |
|
| Web Site |
|
| |
| Products Interested (Browsing products) |
|
| Product ID |
CAS Number |
Product Name |
Quantity |
| A1-0351 |
130284-53-6 |
5-Amino-3-bromo-2-chloropyridine |
|
| A1-0362 |
28489-47-6 |
3-Amino-6-fluoro-2-picoline |
|
| A1-0376 |
407-20-5 |
5-Bromo-3-fluoropyridine |
|
| A1-0387 |
22282-99-1 |
4-Bromo-2-picoline |
|
| A1-0455 |
4684-94-0 |
6-Fluoropyridine-2-carboxylic acid |
|
| A1-0463 |
694-52-0 |
4-Fluoropyridine |
|
| A1-0467 |
72093-04-0 |
3-Chloro-4-picoline |
|
| A1-0474 |
91469-55-5 |
1-Amino-3-cyclopentene, HCl |
|
| A1-2555 |
108612-54-0 |
4-AMINOPIPERIDINE-N-METHYL, N-BOC PROTECTED |
|
| A1-2729 |
55408-11-2 |
5-CHLOROMETHYL-1(2)H-TETRAZOLE |
|
| A1-2734 |
101469-92-5 |
(S)-(+)-N-(TERT-BUTOXYCARBONYL)-3-HYDROXYPYRROLIDINE |
|
| A1-2746 |
59865-13-3 |
CYCLOSPORIN A, TOLYPOCLADIUM INFLATUM |
|
| AS-5306 |
2043-57-4 |
1,1,1,2,2,3,3,4,4,5,5,6,6-Tridecafluoro-8-iodooctane |
|
| JR6-L2179 |
905991-90-4 |
Benzenepropanoic acid, ß-amino-3-chloro-, methyl ester, (ßR)- |
|
| JR6-L2181 |
275826-39-6 |
Benzenepropanoic acid, ß-amino-4-fluoro-, ethyl ester, (ßR)- |
|
| JR6-L2358 |
1071024-05-9 |
4-Thiazolidinecarboxylic acid, 3-(1-oxopentyl)-2-thioxo-, methyl ester, (4S)- |
|
| JR6-L2367 |
764651-39-0 |
4-Penten-1-one, 1-[(4S)-4-phenyl-2-thioxo-3-thiazolidinyl]- |
|
| JR6-L2371 |
933452-88-1 |
1-Pentanone, 1-[(4S)-4-(1-methylethyl)-2-thioxo-3-thiazolidinyl]-5-phenyl- |
|
| JR6-L2372 |
1353031-33-0 |
1,3-Butanedione, 1-[(4R)-4-(phenylmethyl)-2-thioxo-3-thiazolidinyl]- |
|
| JR6-L2740 |
162246-14-2 |
2H-1-Benzopyran-2-one, 3,4-dihydro-6-hydroxy-3-[(4-methylphenyl)methylene]-, (E)- (9CI) |
|
| JR6-L2744 |
1242178-54-6 |
Benzoic acid, 4-[[(6-hydroxy-2-oxo-2H-1-benzopyran-3-yl)carbonyl]amino]-, ethyl ester |
|
| JR6-L2846 |
1251755-21-1 |
1H-Pyrazole-5-carboxylic acid, 3-[3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]propoxy]-, ethyl ester |
|
| JR6-L3257 |
194718-22-4 |
1,1'-Binaphthalene, 2,2'-diisothiocyanato-, (1S)- (9CI) |
|
| JR6-L3270 |
93621-65-9 |
Acetamide, N,N'-[1,1'-binaphthalene]-2,2'-diylbis- |
|
| JR6-L3272 |
345659-25-8 |
Acetamide, N,N'-(1S)-[1,1'-binaphthalene]-2,2'-diylbis- |
|
| JR6-L3275 |
1407532-80-2 |
2(1H)-Pyridinone, 5-acetyl-3-iodo-6-methyl- |
|
| JR6-L3278 |
1174665-76-9 |
3-Pyridinecarboxylic acid, 1,6-dihydro-5-iodo-2-methyl-6-oxo-, ethyl ester |
|
| JR6-L3963 |
944267-38-3 |
Methanone, (2,3-difluorophenyl)-1H-imidazol-2-yl- |
|
| JR6-L3966 |
128566-17-6 |
Methanone, (2,3-difluorophenyl)(3,4-dimethoxyphenyl)- |
|
| JR6-L4163 |
922178-94-7 |
Benzenebutanoic acid, ß-[[(1,1-dimethylethoxy)carbonyl]amino]-2,4,5-trifluoro-, (ßS)- |
|
| JR6-L4165 |
611240-47-2 |
Benzenebutanoic acid, 4-chloro-ß-[[(1,1-dimethylethoxy)carbonyl]amino]-2,5-difluoro-, (ßR)- |
|
| JR6-L4167 |
945262-22-6 |
Benzenebutanoic acid, 2-chloro-ß-[[(1,1-dimethylethoxy)carbonyl]amino]-4,5-difluoro-, (ßR)- |
|
| JR6-L4511 |
179756-43-5 |
1-Pyrrolidinecarboxylic acid, 3-(4-aminophenoxy)-, 1,1-dimethylethyl ester, (3S)- |
|
| JR6-L4513 |
1224514-70-8 |
1-Pyrrolidinecarboxylic acid, 3-(2-pyridinyloxy)-, 1,1-dimethylethyl ester, (3S)- |
|
| JR6-L4515 |
1400760-66-8 |
1-Pyrrolidinecarboxylic acid, 3-(4-pyridinylmethoxy)-, 1,1-dimethylethyl ester, (3S)- |
|
| JR6-L4517 |
1236861-83-8 |
1-Pyrrolidinecarboxylic acid, 3-(2-pyrimidinyloxy)-, 1,1-dimethylethyl ester, (3S)- |
|
| JR6-L4891 |
485828-73-7 |
Cyclobutanecarbonitrile, 1-(1,3-benzodioxol-4-yl)- |
|
| JR6-L4897 |
1260888-51-4 |
Cyclobutanecarbonitrile, 1-[2-(trifluoromethoxy)phenyl]- |
|
| JR6-L5512 |
858114-76-8 |
Oxazole, 2-chloro-5-methyl-4-phenyl- |
|
| JR6-L5513 |
819076-91-0 |
6-Benzoxazolecarboxylic acid, 2-chloro-, methyl ester |
|
| JR6-L5819 |
942153-04-0 |
4-Morpholinecarboxylic acid, 3-[[[(1S)-1-phenylethyl]amino]carbonyl]-, 9H-fluoren-9-ylmethyl ester, (3S)- |
|
| JR6-L6029 |
1227909-28-5 |
2,4-Pyrimidinediamine, 6-(3-amino-1H-indazol-6-yl)-N4-(phenylmethyl)- |
|
| JR6-L6051 |
1374877-26-5 |
[1]Benzothieno[3,2-d]pyrimidine-2,4-diamine, N4-(phenylmethyl)-, 5,5-dioxide |
|
| JR6-L6217 |
99735-44-1 |
3-Pyrrolidinecarboxylic acid, 5-oxo-1-[(1R)-1-phenylethyl]-, (3S)- |
|
| JR6-L6219 |
428518-36-9 |
3-Pyrrolidinecarboxylic acid, 5-oxo-1-(phenylmethyl)-, methyl ester, (3R)- |
|
| JR6-L6225 |
1245645-24-2 |
3-Pyrrolidinemethanol, a,a-dimethyl-, (3S)- |
|
| JR6-L6229 |
428518-43-8 |
3-Pyrrolidinecarboxylic acid, methyl ester, (3R)- |
|
| JR6-L6245 |
216311-59-0 |
3-Pyrrolidinecarboxylic acid, 1-(phenylmethyl)-, methyl ester, (3R)- |
|
| JR6-L6256 |
483366-66-1 |
Benzonitrile, 3-fluoro-5-[(3S)-3-(hydroxymethyl)-1-pyrrolidinyl]- |
|
| JR6-L6260 |
1353101-89-9 |
5-Thiazolecarboxylic acid, 4-amino- |
|
| JR6-L6583 |
121959-61-3 |
(R)-4-Vinyldihydrofuran-2(3H)-one |
|
| JR6-L6584 |
|
(S)-4-Vinyldihydrofuran-2(3H)-one |
|
| JR6-L6587 |
24340-77-0 |
Isothiazole, 4-bromo- |
|
| JR6-L6589 |
4415-82-1 |
Cyclobutanemethanol |
|
| JR6-L6604 |
86688-08-6 |
R-(+)-2,2-Dibromo-1,1'-binaphthyl |
|
| JR6-L7398 |
1432620-26-2 |
3-Pyridineethanol, a-methyl-, (aS)- |
|
| JR6-L7405 |
1432621-22-1 |
3-Pyridineethanol, 2-methoxy-a-methyl-, (aR)- |
|
| JR6-L7410 |
1432620-55-7 |
3-Pyridineethanol, a-methyl-6-(1-piperidinyl)-, (aS)- |
|
| JR6-L7683 |
1344446-77-0 |
Benzeneacetic acid, a-amino-4-ethynyl-a-(trifluoromethyl)-, (aR)- |
|
| JR6-L8782 |
213963-87-2 |
4-Decen-2-ol, 1-chloro-, (2R,4Z)- |
|
| JR6-L8783 |
139071-37-7 |
Butanal, 4-chloro-3-[(trimethylsilyl)oxy]-, (3R)- |
|
| JR8-N0181 |
28608-75-5 |
Orientin |
|
| JR8-N0190 |
6902-91-6 |
Germacrone |
|
| JR8-N0257 |
52286-58-5 |
Ginsenoside Rf |
|
| JR8-N0262 |
62025-49-4 |
Ginsenoside F2 |
|
| JR8-N0311 |
17306-46-6 |
Rhoifolin |
|
| JR8-N0580 |
35790-95-5 |
a-hederin |
|
| JR8-N1114 |
30557-81-4 |
Bisabolangelone |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
| Comments |
| |
|
 |
|
|
|
|
|
|